First-in-human phase I trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory prostate cancer

被引：5
|
作者：
Kantoff, P.
Petrylak, D. P.
Pomerantz, M.
Israel, R. J.
Olson, W. C.
Ramakrishna, T.
Morris, S.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Columbia Univ, Med Ctr, New York, NY USA
[3] Progen Pharmaceut Inc, Tarrytown, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.tps245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS245
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in taxane-refractory prostate cancer
    Petrylak, D. P.
    Kantoff, P. W.
    Rotshteyn, Y.
    Israel, R. J.
    Olson, W. C.
    Ramakrishna, T.
    Morris, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [2] Prostate-specific membrane antigen antibody-drug conjugate (PSMA ADC): A phase I trial in taxane-refractory prostate cancer.
    Petrylak, D. P.
    Kantoff, P. W.
    Frank, R. C.
    Shore, N. D.
    Rotshteyn, Y.
    Israel, R. J.
    Olson, W. C.
    Ramakrishna, T.
    Morris, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] A phase 2 trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC).
    Petrylak, Daniel Peter
    Smith, David C.
    Appleman, Leonard Joseph
    Fleming, Mark T.
    Hussain, Arif
    Dreicer, Robert
    Sartor, A. Oliver
    Shore, Neal D.
    Vogelzang, Nicholas J.
    Youssoufian, Hagop
    DiPippo, Vincent A.
    Stambler, Nancy
    Huang, Kathleen
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A phase II trial of prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) in taxane-refractory metastatic castration-resistant prostate cancer (mCRPC).
    Petrylak, Daniel Peter
    Smith, David C.
    Appleman, Leonard Joseph
    Fleming, Mark T.
    Hussain, Arif
    Dreicer, Robert
    Sartor, A. Oliver
    Shore, Neal D.
    Vogelzang, Nicholas J.
    Youssoufian, Hagop
    Olson, William C.
    Stambler, Nancy
    Huang, Kathleen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [5] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in men with prostate cancer previously treated with taxane.
    Petrylak, Daniel Peter
    Kantoff, Philip W.
    Mega, Anthony E.
    Dreicer, Robert
    Frank, Richard C.
    Shore, Neal D.
    Morris, Stephen
    Olson, William C.
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [6] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane
    Petrylak, Daniel Peter
    Kantoff, Philip W.
    Mega, Anthony E.
    Vogelzang, Nicholas J.
    Stephenson, Joe
    Fleming, Mark T.
    Stambler, Nancy
    Petrini, Michaela
    Huang, Kathleen
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [7] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane
    Petrylak, Daniel Peter
    Kantoff, Philip W.
    Mega, Anthony E.
    Vogelzang, Nicholas J.
    Stephenson, Joe
    Fleming, Mark T.
    Stambler, Nancy
    Petrini, Michaela
    Blattman, Sara
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Prostate-specific membrane antigen antibody drug conjugate (PSMA ADC): A phase I trial in metastatic castration-resistant prostate cancer (mCRPC) previously treated with a taxane.
    Mega, Anthony E.
    Petrylak, Daniel Peter
    Kantoff, Philip
    Stephenson, Joe
    Vogelzang, Nicholas J.
    Dreicer, Robert
    Shore, Neal D.
    Stambler, Nancy
    Carpenito, Jennifer
    D'Ambrosio, Paul
    Israel, Robert Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
    Petrylak, Daniel P.
    Kantoff, Philip
    Vogelzang, Nicholas J.
    Mega, Anthony
    Fleming, Mark T.
    Stephenson, Joe J., Jr.
    Frank, Richard
    Shore, Neal D.
    Dreicer, Robert
    McClay, Edward F.
    Berry, William R.
    Agarwal, Manish
    DiPippo, Vincent A.
    Rotshteyn, Yakov
    Stambler, Nancy
    Olson, William C.
    Morris, Stephen A.
    Israel, Robert J.
    PROSTATE, 2019, 79 (06): : 604 - 613
  • [10] A PHASE 2 TRIAL OF PROSTATE SPECIFIC MEMBRANE ANTIGEN ANTIBODY DRUG CONJUGATE (PSMA ADC) IN TAXANE-TREATED METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)
    Petrylak, Daniel
    Smith, David C.
    Appleman, Leonard J.
    Fleming, Mark
    Hussain, Arif
    Dreicer, Robert
    Sartor, A. Oliver
    Shore, Neil
    Vogelzang, Nicholas J.
    Youssoufian, Hagop
    Olson, William
    Stambler, Nancy
    Huang, Kathleen
    Israel, Robert
    JOURNAL OF UROLOGY, 2014, 191 (04): : E813 - E814
12345